Abivax (AAVXF) Change in Intangibles (2024)
Abivax (AAVXF) posted Change in Intangibles of -$3.2 million for Q4 2024.
Powered by 
Analysis
Abivax (AAVXF) Change in Intangibles (2024) Analysis & Trends
Abivax has reported Change in Intangibles for 1 years, with the latest figure at -$3.2 million in Q4 2024.
- On a quarterly basis, Change in Intangibles changed N/A year-over-year to -$3.2 million in Q4 2024; TTM through Dec 2025 was -$3.2 million, a N/A change from a year earlier, with the FY2024 full-year figure at -$3.2 million, changed N/A from the prior year.
- Change in Intangibles was -$3.2 million for Q4 2024 at Abivax.
- The five-year high for Change in Intangibles was -$3.2 million in Q4 2024, with the low at -$3.2 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.28 Bn | 197.29 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.28 Bn | 178.10 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.26 Bn | 124.41 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.58 Bn | 74.58 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.67 Bn | 56.48 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.58 Bn | 49.44 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.01 Bn | 30.70 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.26 Bn | 29.98 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.78 Bn | 29.78 Bn | 1.16 Mn | - |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | - |